2017
$74M
from 12 investors over 12 rounds
Agomab Therapeutics raised $39M on July 13, 2022
Investors: Asabys Partners and Walleye Capital
Agomab Therapeutics raised $74M on March 10, 2021
Investors: V-Bio Ventures, Omnes, Redmile Group, Pontifax Venture Capital, AdBio partners and Andera Partners
Agomab Therapeutics raised $24M on April 3, 2019
Investors: AdBio partners, Omnes, V-Bio Ventures and Pontifax Venture Capital